MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
出版年份 2016 全文链接
标题
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
作者
关键词
-
出版物
Multiple Sclerosis Journal
Volume 22, Issue 13, Pages 1719-1731
出版商
SAGE Publications
发表日期
2016-09-02
DOI
10.1177/1352458516667568
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis
- (2016) Frédéric Sedel et al. NEUROPHARMACOLOGY
- Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios
- (2015) Ali Manouchehrinia et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- High doses of biotin in chronic progressive multiple sclerosis: A pilot study
- (2015) Frédéric Sedel et al. Multiple Sclerosis and Related Disorders
- New Multiple Sclerosis Phenotypic Classification
- (2014) Fred D. Lublin EUROPEAN NEUROLOGY
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
- (2014) Dean M. Wingerchuk et al. MAYO CLINIC PROCEEDINGS
- Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
- (2014) P. Browne et al. NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS
- (2013) J. Hobart et al. NEUROLOGY
- Will the real multiple sclerosis please stand up?
- (2012) Peter K. Stys et al. NATURE REVIEWS NEUROSCIENCE
- Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study
- (2012) Nilika G. Wijeratne et al. PATHOLOGY
- A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
- (2011) M. S. Freedman et al. NEUROLOGY
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
- (2009) Bruce D Trapp et al. LANCET NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started